Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Molfetta

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Immunology|August 15, 2021
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activationCinzia Fionda, Helena Stabile, Rosa Molfetta, et al.
ACS Applied Bio Materials|May 22, 2024
Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based NanoparticlesFrancesca Giulimondi, Luca Digiacomo, Serena Renzi, et al.
Scientific Reports|September 7, 2017
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cellsBeatrice Zitti, Rosa Molfetta, Cinzia Fionda, et al.
Cell Death & Disease|November 28, 2025
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myelomaElena Sproviero, Eleonora Gnocchini, Tommaso Cipollone, et al.
Cell Death & Disease|July 17, 2023
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cellsSara Petillo, Elena Sproviero, Luisa Loconte, et al.
Oncotarget|August 14, 2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myelomaCinzia Fionda, Maria Pia Abruzzese, Alessandra Zingoni, et al.
Cell Death & Disease|September 5, 2021
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognitionSara Petillo, Cristina Capuano, Rosa Molfetta, et al.
Cell Death & Disease|September 20, 2023
SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironmentRosa Molfetta, Mario Lecce, Nadia D Milito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2019
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanismsMaria Teresa Bilotta, Maria Pia Abruzzese, Rosa Molfetta, et al.
Journal of Hematology & Oncology|December 2, 2016
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplayMaria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|August 15, 2021
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activationCinzia Fionda, Helena Stabile, Rosa Molfetta, et al.
ACS Applied Bio Materials|May 22, 2024
Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based NanoparticlesFrancesca Giulimondi, Luca Digiacomo, Serena Renzi, et al.
Scientific Reports|September 7, 2017
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cellsBeatrice Zitti, Rosa Molfetta, Cinzia Fionda, et al.
Cell Death & Disease|November 28, 2025
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myelomaElena Sproviero, Eleonora Gnocchini, Tommaso Cipollone, et al.
Cell Death & Disease|July 17, 2023
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cellsSara Petillo, Elena Sproviero, Luisa Loconte, et al.
Oncotarget|August 14, 2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myelomaCinzia Fionda, Maria Pia Abruzzese, Alessandra Zingoni, et al.
Cell Death & Disease|September 5, 2021
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognitionSara Petillo, Cristina Capuano, Rosa Molfetta, et al.
Cell Death & Disease|September 20, 2023
SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironmentRosa Molfetta, Mario Lecce, Nadia D Milito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2019
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanismsMaria Teresa Bilotta, Maria Pia Abruzzese, Rosa Molfetta, et al.
Journal of Hematology & Oncology|December 2, 2016
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplayMaria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Pageof 6